CD8A and neoplasm: It turned out that patients with TKI-PFS less than 10 months had significantly higher proportion of CD45+ in live cells, CD3+ in lymphocytes, CD8+ in CD3+ T cells and INF-γ+CD8+ in CD3+ T cells infiltrated in the tumor microenvironment (TME) (Figure 4I).